Merck (NYSE: MRK) reported Q3 EPS of $2.58, $0.23 better than the analyst estimate of $2.35. Revenue for the quarter came in at $17.28 billion versus the consensus estimate of $16.98 billion.

GUIDANCE:

Merck sees FY2025 EPS of $8.93-$8.98, versus the consensus of $8.89. Merck sees FY2025 revenue of $64.5-65 billion, versus the consensus of $64.81 billion.

For earnings history and earnings-related data on Merck (MRK) click here.